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BACKGROUND: The goal of our study  was to  examine
spontaneous and stimulated apoptosis of peripheral
blood MNC from allergic patients, sensitized to Der p
I  antigen  as  compared  to  cells  from  non-atopic
subjects. Furthermore we aimed to investigate which
populations  of  mononuclear  cells  (lymphocytes,
monocytes) undergo the apoptosis and to determine
relations between apoptosis and serum levels of sFas/
APO-1, ICE/caspase-1 or TNF-a .
Methods:  The  study  included  17  patients  with  per-
ennial, allergic asthma and/or allergic rhinitis [6 male
and 11 female; mean age 29,5 years; (range 15–49)].
Apoptosis was assessed by fluorescence technique
and confirmed by flow-cytometric method and DNA
ladder. Serum levels of sFas, ICE/caspase-1 or TNF-a
were determined by immunoassays (ELISA).
Results:  Apoptotic  index  of  unfractionated  mono-
nuclear cells (MNC) and lymphocytes (but not mono-
cytes) were significantly higher in allergic patients as
compared  to  non-allergic  subjects  after  48  and  72
hours  of  culture  (p<0.05).  Incubation  of  cells  with
ConA (10 m g/ml) resulted in a significant increase in
the proportion of apoptotic cells in all populations
once the apoptotic index for MNC and lymphocytes
(but not monocytes) was again significantly higher in
allergic as compared to non-allergic subjects after 24,
48 and 72 hour of culture.
In  allergic  patients,  mean  serum  sFas  level,  was
significantly lower then in non-allergic group (mean
value 624.8pg/ml ± 25.67 versus 802.0pg/ml ± 31.91;
p = 0.003) and in both groups sFas level correlated
inversely  with  apoptosis  of  MNC.  The  mean  ICE/
caspase-1  concentration was significantly  higher in
sera of allergic patients as compared to non-allergic
group (mean value 27.71pg/ml ± 3.79 vs. 23.54pg/ml
respectively; p<0.01). ICE/caspase-1 levels in allergic
patients  correlated  with  apoptotic  index  of  mono-
nuclear cells (r = 0.57; p<0.001).
Conclusions: An increased spontaneous and mitogen-
induced apoptosis of MNC from peripheral blood of
atopic  patients  as well as different serum levels of
sFas  and  ICE/caspase-1  correlating  with  apoptosis,
suggest different regulation of apoptotic  process in
peripheral blood mononuclear cells of patients with
allergic asthma and/or rhinitis.
Abbreviations:  MNC-mononuclear  cells;  PCD-  program-
med cell death; TNF- tumor necrosis factor; ICE/caspase-1 –
Interleukin 1b converting enzyme; ConA – Concanavalin A;
PI – Propidium iodide;
Key words: Atopic asthma,  apoptosis,  allergic  inflamma-
tion, mononuclear cells, sFas/APO–1, TNFR, caspases.
Introduction
Mononuclear cells (MNC) including  monocytes and
T-cells, constitute a proportion of cellular infiltrate in
the asthmatic airway mucosa and play  a significant
role  in  the  pathogenesis  of  allergic  airway  inflam-
mation.1 Both monocytes and T-cells are the source
of several cytokines and chemokines with proinflam-
matory  activity  stimulating  and  perpetuating
allergic  inflammation.2,3,4,5,6 Development  of
chronic  inflammation  involves  the  absence  of  bal-
ance  between  proliferation  and  elimination  of  the
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mechanisms:  necrosis  and  apoptosis.  Necrosis  is  a
pathologic form  of  cell  death  resulting  from  acute
cellular injury, and typified by rapid cell swelling and
lysis.  Shrinkage,  nuclear  condensation,  and  mem-
brane blabbing and membrane changes that lead to
phagocytosis of the affected cell characterize apop-
tosis  (programmed  cell  death;  PCD).7 Recent  data
suggest that mechanisms involved in the regulation
of  the survival and apoptosis of  inflammatory cells
may  play  a central role in  the persistent inflamma-
tory process characterizing allergy and asthma. How-
ever,  most  studies  focussed  so  far  an  apoptosis  of
eosinophils, al thought survival of lymphocytes may
be  also  an  employed  factor  regulating  allergic
inflammation.8
During  activation  by  specific  antigen,  T  helper
lymphocytes synthesize several growth factors e.g. IL-
2, which induce proliferation of specific T lympho-
cytes. Although IL-2 prevents apoptosis by regulation
of synthesis proteins such as Bcl-2 and Bcl-xL, during
specific  activation some T  cells undergo apoptosis.
Triggering of specific cellular receptors, such as TNF
receptor superfamily, can also induce PCD.9,10,11 The
pivotal  functions  in  apoptotic  pathways  play  Cyto-
solic  Aspartate-Specific  Proteases,  called  Caspases.
They are present in all cells as latent enzymes and are
recruited  to  receptor-associated cytosolic  complex,
which is formed by initiation of receptor oligomeriza-
tion  (e.g.,  TNF-receptors,  FAS, TRAIL).  During  the
activation  caspases  can  initiate  a  cascade  of  intra-
cellular  events  leading  to  apoptosis.  ICE/caspase-1
(Interleukin-1b?converting  enzyme)  was  the  first
member  of the caspase family  to be identified as a
novel type of  cysteine protease responsible for  the
conversion of  precursor interleukin-1  to  its mature
form in monocytes. The mature form of IL-1b claved
at Asp-116-Ala-117  is  a  key  mediator  of  inflamma-
tion.12,13 Programmed  cell  death  play  a  significant
role in immunological processes such as transplanta-
tion  and  graft-versus-host  reaction  but  in  allergic
diseases the role of apoptosis in unclear yet.
The goal of our study was to examine spontaneous
and  stimulated  apoptosis of  peripheral  blood  MNC
from allergic patients, sensitized to Der p I antigen as
compared  to  apoptosis  of  cells  from  non-atopic
subjects. Furthermore we aimed to investigate which
populations  of  mononuclear  cells  (lymphocytes,
monocytes) undergo the apoptosis and to determine
relations  between  apoptosis  and  serums  levels  of
sFas/APO-1, ICE/caspase-1 or TNF-a.
Patients and methods
Patients
The study included 17 patients with perennial, mild
bronchial asthma and/or allergic rhinitis [6 male and
11 female; mean age 29.5 years (range 15–49)]. All
patients  had positive skin  prick  tests  with Der  p  I
antigen  and  some  of  them  were  also  sensitized  to
other seasonal or  perennial  allergens. All  asthmatic
patients  were  on  inhaled  steroids  (not  exceeding
200mg of budesonide), but none of them had taken
oral corticosteroids. Methyloxantins or shorts acting
antihistamines were stopped at least 72 hours before
the  blood  samples  were  obtained.  (Table  1)  The
control  group  comprised  16  subjects  without  any
symptoms or history concerning the respiratory tract
and  with  negative  skin  prick  tests  to  a  battery  of
inhalant allergen.
Cells isolation
Mononuclear  cells  were  isolated  with  Boy¨ um’s
method.14 In brief: 20ml heparinized venous blood
were  mixed  with  PBS  in  1:3  proportion,  then
carefully  stratified  on  Histopaque  1.07g/cm3
(Sigma,  Germany)  and  centrifuged  at  400  ´ g  for
200min. The  ring  which  was  formed  on  the  bor-
derline  of  the  phases  was  carefully  collected  and
rinsed  in  phosphate  buffer  (pH  7.4  without  Ca++
and Mg++).  Finally,  suspended in  the  medium  sup-
plemented with 0.3% albumin, Ca++ and Mg++, and
0.036% glucose so that the number of cells equaled
2´ 106/ml.  One  aliquot  of  MNC  suspension  was
cultured. The second was used to assay cell surface
markers. The  composition  of  unfractionated PBMC
was  tested  by  immunofluorescence  method  with
monoclonal  antibodies:  anti  –  CD2,  CD3,  CD4,
CD8,  CD22,  CD56,  CD14  (DAKO,  Holland).  The
residual  portion  cells  from  12  out  of  17  patients
were  further  isolated into  lymphocytes  and  mono-
cytes  by  adherence  on  plastic  dishes.  Briefly:  the
mononuclear  cells  were  resuspended  in  medium
enriched with antibiotics (penicillin – 100U/ml and
J. Grzegorczyk et al.
226 Mediators of Inflammation · Vol 11 · 2002
Table 1. Characteristics of allergic patients.
NR Initials Sex Age in years Clinical diagnosis
1 R. A. F 28 Rhinitis
2 P. A F 47 Asthma + Rhinitis
3 K. G M 21 Asthma + Rhinitis
4 W. Z M 40 Asthma + Rhinitis
5 B. R M 19 Asthma + Rhinitis
6 K. P F 18 Rhinitis
7 N. R F 22 Asthma + Rhinitis
8 B. A F 30 Asthma + Rhinitis
9 J. I F 20 Asthma + Rhinitis
10 P. M F 38 Asthma + Rhinitis
11 D. A F 49 Asthma + Rhinitis
12 F. A F 22 Asthma + Rhinitis
13 C. S M 19 Asthma + Rhinitis
14 S. A F 29 Asthma + Rhinitis
15 K. W F 47 Asthma + Rhinitis
16 W. W M 39 Rhinitis
17 K. B M 15 Asthma + Rhinitisstreptomycin  –  10mg/ml)  at  final  concentration of
2´ 106/ml. Five milliliter aliquots of cells were incu-
bated  in  plastic  dishes  at  37°C  in  5%  CO2 for  1
hour. Non-adherent cells were removed by vigorous
washing  and  the  adherent  cells  by  scraping  with
rubber  policemen.  The  adherent  cells  were  typi-
cally  >65%  monocytes,  as  assessed  by  immuno-
fluorescence  method  with  monoclonal  anti-CD14
antibody15 and  the  remaining  cells  were
lymphocytes.
Cell culturing and assessment of apoptosis
Unfractionated MNC (both lymphocytes and mono-
cytes) were cultured16 for indicated period of time
with  ConA  (10mg/ml)  or  with  the  medium  alone.
The  samples  were  preincubated  (with  or  without
ConA) for 4h in the incubator with 5% CO2 and 95%
humidity  at  37°C.  Following  preincubation,  cells
were washed twice in PBS without Ca++ and Mg++,
suspended  in  the  primary  medium  volume,  and
cultured for 24, 48 and 72 hours.
The MNC were removed from culture after 24, 48
and 72 hours to study apoptosis by the fluorescence
technique,  as  described McGahon.17 Twenty-five ml
aliquots  of  MNC  were  mixed  with  PBS  solutions
containing  100mg/ml  of  acridine  orange  base
(Sigma)  for  assessment  of  nuclear  morphologic
characteristics  and  100ml/ml  ethidium  bromide
(Sigma)  for  assessment  of  cellular  viability.  Stained
MNC  were  transferred  to  a  glass  slide  and
examined  by  means  of  fluorescence  microscope.
Minimum  of  200  total  cells  was  counted  and  the
number  of  apoptotic  cells  with  highly  condensed
chromatin was recorded. (Fig. 1). The percentage of
apoptotic cells  (apoptotic index)  was calculated as
follows:
% Apoptotic cells =
Total number cells with apoptotic nuclei ´ 100
Total number cells counted
(viable+apoptotic +necrotic cells)
Flow-cytometric determination of apoptosis
MNC from 6 subjects (3 atopic asthmatic patients and
3  healthy  persons)  were  examined  by  cytofluory-
metry. Annexin V-FITC- 5ml and PI-10ml (PharMingen,
USA)  were  used  to  quantitatively  determine  the
percentage  of  cells  undergoing  apoptosis  18 The
following controls were used to set up compensation
and  quadrants:  unstained  cells;  cells  stained  with
Annexin V-FITC  (no  PI);  cells  stained  with  PI  (no
Annexin V-FITC).
Isolation of apoptotic DNA fragments
Fragmentation  of  DNA  was  assessed  according  to
Herman.19The MNC were removed from culture after
72 hours. After harvesting MNC samples were washed
with PBS and pelted by centrifugation. The cell pellets
were then treated for 10s with lysis buffer (1% NP –40
in 20 mM EDTA, 50 mM Tris-HCL, pH–7.5; 10ml per
106 cells). After centrifugation the supernatants were
brought to 1% SDS and treated for 2h with RNAse at
56°C. Followed by digestion with proteinase K for at
last  2h  at  37°C.  After  addition  of 
1￿ 2 vol.  10M
ammonium acetate, the DNA was precipitated with
2.5 vol. ethanol. Next, separated by electrophoresis in
1-% agarose gel containing ethidium bromide (i.e. 35V
for approximately 4h). The samples were visualized
by  UV  illumination  and  analyzed  by  gel  analyzing
system (Vilber Lourmat, France).
sFas/APO-1, ICE/caspase-1 and TNF-a
measurment in serum
The  serum  in  the  same  sample  of  blood,  were
collected  and  frozen  at  –20°C  until  the  time  of
determination of sFas/APO-1 (PharMingen); ICE/cas-
pase-1  and  TNF-a (Bender  MedSystems)  by  ELISA
method.
Statistical analyses
Wilcoxon’s  or  F  tests  were  applied  to  statistically
analyze the data. Spearman’s test and regression were
used to assess relation between level sFas/APO-1, ICE/
caspase-1, TNF-a and baseline time (T0) apoptosis.
Results
We  did  not  observe  any  significant  differences
between MNC surface markers in  allergic and non-
allergic subjects (data not shown).
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FIG.  1.  Apoptotic  morphological  changes  in  mononuclear
cells stained with orange acridine and ethidium bromide. A –
alive lymphocyte; B – D different morphological changes in
apoptotic lymphocytes; E  –  necrotic  lymphocyte. (Fluores-
cence microscope; 200x).J. Grzegorczyk et al.
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Table 2. Spontaneous and Con A stimulated apoptosis of MNC in allergic (n = 12) and non-allergic subjects (n = 16).
Allergic patients
24 hrs 48 hrs 72 hrs
Non-allergic subjects
24 hrs 48 hrs 72 hrs
MNC Spontaneous 19.33 ± 1.48 33.58 ± 3.59* 43.33 ± 4.02* 16.81 ± 1.36 21.21 ± 21.6 26.59 ± 2.38
Con A 47.7 ± 3.96 54.3 ± 4.07 54.67 ± 4.02 35.28 ± 12.55 39.14 ± 2.9 40.0 ± 3.57
Lymphocytes Spontaneous 9.66 ± 0.99 20.25 ± 2.2* 28.33 ± 3.93* 9.00 ± 0.76 14.7 ±1.07 19.87 ± 1.79
Con A 51.66 ± 2.79* 55.83± 2.21* 49.91 ± 5.22* 31.42 ± 1.37 33.42 ± 2.06 31.85 ± 2.89
Monocytes spontaneous 28.33 ± 2.7 31.5 ± 2.4 36.58 ± 3.78 27.03 ± 2.88 33.96 ± 2.84 35.9 ± 3.53
Con A 54.58 ± 2.21 59.5 ± 2.96 57.33 ± 3.48 39.57 ± 2.79 40.0 ± 3.09 40.85 ± 3.85
*Significant difference (p<0.05) as compared to non-allergic subjects. Following ConA stimulation apoptosis was significantly enhanced (p<0.05) for all
cell populations at all time-points.
FIG. 2 Spontaneous apoptosis of cells in allergic and non-allergic subjects; (–) mean value; (a) Unfractionated mononuclear
cells (MNC); (b) Lymphocytes.A significant  proportion of unfractioneted mono-
nuclear  cells,  (both  lymphocytes  and  monocytes)
demonstrated  apoptosis  immediately  after  isolation
(T0),  and after 24,  48  and 72  hours of culture  the
apoptotic index for all cell populations significantly
increased.  (Table  2). Apoptotic  index  of  unfractio-
nated MNC and lymphocytes was significantly higher
in  allergic  patients  as  compared  to  non-allergic
subjects after 48 and 72 hours of culture (p < 0,05).
Figure 2a,b. The proportion of apoptotic monocytes
was  not  different  between  atopic  and  non-atopic
subjects at any time.
Incubation of cells with Con A (10mg/ml) resulted
in a significant increase in the proportion of apoptotic
cells in all cell populations. The apoptotic index for
MNC and  lymphocytes  were  significantly  higher  in
atopic as compared to non-atopic subjects at 24, 48
and 72 hour of culture with ConA.
Flow-cytometric analysis
In  order  to  confirm  morphologic  observations,
apoptosis of MNC was further analyzed in 3 allergic
and  3  non-allergic  patients  by  cytofluorymetry.
Again  a  higher  proportion  of  apoptotic  cells  was
detected  in  allergic  as  compared  to  non-allergic
subjects. Table 3.
Representative  plots  for  allergic  and  non-allergic
subjects are shown in Figure 3.
DNA fragmentation
The  presence of  apoptosis was  confirmed by  DNA
ladder. The fragmentation of DNA was observed after
72hrs culture of MNC only in those atopic patients, in
whom the percentage of apoptotic cells was higher
then 50% (n = 4). No fragmentation of DNA could be
Apoptosis of mononuclear cells from allergic patients
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Table 3. Apoptosis of MNC in allergic patients (n = 3) and non-allergic subjects (n = 3) examined by cytofluorymetry with
Annexin V-FITC and PI. (AxV- Annexin V, PI- Propidium Iodine, SE- standard error, Sp.- spontaneous).
Allergic patients
AxV(+)PI(–)
Mean ± SE
AxV(+)PI(+)
Mean ± SE
Together
Mean ± SE
Non-allergic subjects
AxV(+)PI(–)
Mean ± SE
AxV(+)PI(+)
Mean ± SE
Together
Mean ± SE
Baseline To 18.1 ± 3.45 2.9 ± 1.1* 21.0 ± 3.8 14.4 ± 5.9 7.7 ± 4.5 22.2 ± 7.9
24h sp. 27.2 ± 9.0 * 13.3 ± 6.8 40.4 ± 13.4 15.1 ± 1.8 11.5 ± 8.3 26.6 ± 9.2
24h ConA 51.2 ± 9.1 18.8 ± 8.8 70.4 ± 11.9 31.9 ± 5.9 35.9 ± 11.9 68.1 ± 14.5
48h sp. 27.3 ± 7.7 27.6 ± 16.3 54.7 ± 11.6 19.9 ± 10.4 24.9 ± 19.3 44.6 ± 17.8
48h ConA 36.8 ± 9.6 39.1 ± 16.2 75.9 ± 9.4 33.8 ± 14.7 34.7 ± 18.4 68.9 ± 17.6
72h sp. 34.6 ± 9.1 38.3 ± 15.9 77.8 ± 10.6 18.2 ± 5.9 51.5 ± 19.0 72.3 ± 18.7
72h ConA 34.6 ± 9.1 41.7 ± 15.7 76.2 ± 11.8 26.9 ± 8.8 48.4 ± 18.8 76.0 ± 14.9
*p < 0.05; significantly different from non-allergic control.
FIG. 3. Representative dotplots for cytofluorymetric method. Spontaneous and ConA stimulated (48h) apoptosis of MNC in an
allergic patient (a and b panels); spontaneous and ConA(48h) stimulated apoptosis in non-allergic subject (c and d panels).detested in  atopic patients  with apoptotic index <
50% (n = 6) or in non-atopic subjects (n = 4).
Serum sFas levels
In  allergic  patients,  mean  serum  sFas  level,  was
significantly lower then in non-allergic group (mean
value 624.8pg/ml ± 25.67 versus 802.0pg/ml ± 31.9;
p = 0.003). Figure 4. There was an inverse correlation
between sFas and baseline (T0) apoptosis of MNC in
both groups (r = –0.12; p < 0.001).
Serum ICE/caspase-1 levels
The  mean  ICE/caspase-1  concentration  was  signifi-
cantly  higher  in  sera  of  allergic  patients  as
compared  to  non-atopic  group  (mean  value
27.71pg/ml  ±  3.79  vs.  23.54pg/ml  ±  2.35  respec-
tively; p < 0.01). Figure 5.
Significant relationship between ICE/caspase-1 lev-
els and baseline (T0) apoptosis of MNC was observed
only in atopic asthmatic patients (r = 0.57; p < 0.001).
Figure 6.
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FIG. 4. Serum levels of sFas/APO-1 in an allergic and non-allergic group. (–) mean value.
FIG. 5. ICE/caspase-1 levels in serum of allergic patients and non-allergic subjects. (–) mean valueSerum TNF-a levels
There  was  no  significant  difference  in  sera TNF-a
concentration  between  the  two-studied  group
[12.11pg/ml ± 3.11 (range 0–40pg/ml) and 7.18pg/
ml  ±  2.90  (range  0–26pg/ml)  in  allergic  and  non-
allergic subjects respectively]. A positive correlation
between baseline apoptosis of MNC and serum levels
of TNF-a was found only in non-allergic subjects (r =
0.58; p < 0.001).
Discussion
Our study demonstrated, that immediately after isola-
tion a significant proportion of mononuclear cells in
peripheral  blood  of  asthmatic  patients  and  healthy
subjects undergo apoptosis, and that the percentage
of  apoptotic  cells  increases  with  time  of  culture.
Although  the  original  observation  was  made  with
morphologic  fluorescent  method,  DNA  ladder  and
cytofluorymetry/  Annexin  method  confirmed  the
presence of apoptosis in mononuclear cells.
Interestingly, we found that a significantly  higher
percentage  of  apoptotic  mononuclear  cells  were
present  in  patients  with  allergic  asthma  and/or
rhinitis  as  compared  to  non-allergic  subjects.
Although  patients  suffered  from  perennial  rhinitis
and/or bronchial asthma, at the time of the study they
were in stable conditions and were not taking any oral
medication suggesting, that an increased MNC apop-
tosis in allergic patients was related to their atopic
status  or/and  to  inflammatory  process  in  their  air-
ways.  Moreover  we  have  observed  and  increased
apoptosis  of  MNC  in  atopic  patients  after  cell
stimulation with mitogen Con A indicating the MNC
from  allergic  patients  are  also  more  susceptible  to
induction  of  apoptosis  as  compared  to  non-atopic
MNC.  In  order  to  characterize  the  populations  of
MNC  undergoing  increased  apoptosis  lymphocytes
and  monocytes (adherent cells)  were studied  sepa-
rately. Although both MNC populations demonstrated
apoptosis,  only  apoptosis  of  lymphocytes  was
increased in allergic patients.
The significance of our finding for the pathogenesis
of allergic airway disease is not clear. The lymphocytes
are recruited from the bone marrow to the peripheral
blood and then to the site of allergic inflammation in
the airway. The airway mucosa lymphocytes generate
several cytokines e.g. IL-4, IL-2,  IL-5 and IL-13 with
proinflammatory properties, thus actively participat-
ing  in  the  development  of  the  effector  phase  of
allergic inflammation.20,21,22,23 Increased apoptosis of
lymphocytes in peripheral blood of allergic patients is
in contrast to decreased apoptosis observed at the site
of  inflammation  in  the  bronchial  mucosa  of  asth-
matics.24 However, it is conceivable, that inflamma-
tory mediators (e.g.  proteases, including  caspase-1)
released in the airways may reach cells in peripheral
blood  resulting  in  enhancement of  their apoptosis.
On the other hand the cytokin profile of lymphocytes
in the peripheral blood from allergic patients differ
from  the  profile  of  the  healthy  persons suggesting
that different cell subpopulation at different stage of
activation  are  recruited  from  bone  marrow  to  the
peripheral blood and further  into the airways. This
cells may differ in their response to apoptotic stimuli
(e.g.  Caspase-1) present in  serum,  thus resulting  in
enhanced apoptosis. Increased apoptosis of lympho-
Apoptosis of mononuclear cells from allergic patients
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FIG. 6. Relationship between serum ICE/caspase-1 levels and T0 apoptosis of MNC in an allergic patients.cytes  in  peripheral  blood  could  be  a  regulatory
mechanism down regulating  further  recruitment  of
mononuclear cells to the site of inflammation.
In order to get some insight into the mechanism of
increased apoptosis of  allergic  patients with atopic
allergy,  factors  related  to  apoptosis  sFas,  caspase-1
and TNF-a were measured in serum in parallel with
assessment of apoptosis. Fas antigen is a member of
the  tumor  necrosis  factor  receptor  superfamily
responsible  for  controlling  of  the  cell  death  sig-
nal.25,26 Cell-surface  Fas  occurs  also  as  a  soluble
protein sFas which can be detected in serum. In this
study, we demonstrated significantly lower serum sFas
in  allergic  asthmatic  patients  as  compared  to  non-
atopic subjects. Our observation is line with previous
study of Kato et al.27 who described lower levels of
serum  sFas  in  patients  with  symptomatic  allergic
rhinitis as compared to healthy persons. Jayaraman S,
et  al.28 observed,  that  asthmatic  subjects  had  23%
lower levels of Fas + T cells (in the airway mucosa)
during treatment with glucocorticoids and suggested
that selective resistance to Fas-dependent apoptosis
may  reflect  altered  antigen-driven,  accessory  cell-
dependent signaling.  Downregulation of  Fas  mRNA
and  surface  Fas  receptor  on  pulmonary  CD3+  T
lymphocytes  from  patients  with  asthma  were  also
reported.29 These  data  suggest  that  an  ineffective
activation of Fas signal transduction at airway mucosa
may contribute to increased T cell-dependent inflam-
mation in asthma. However, in recent study the INF-g
+ but not IL-4+ T cells in the asthmatic biopsies had
significantly  higher  proportions  of  apoptotic  cells
compared with the control group.30 In our study, the
number of apoptotic lymphocytes in peripheral blood
was increased in allergic patients and sFas concentra-
tion demonstrated a weak but statistically significant
negative  correlation  with  apoptotic  index  in  both
allergic and non-allergic subjects, indicating a possi-
ble  and  unexplained  relationship  between  sFas
release and the rate of MNC apoptosis.
Apoptosis is implemented by intracellular activity
of  a  family  of  cysteine  proteases  called  caspases.
Activation  of  cascade  caspases  during  apoptosis
results in the cleavage of critical cellular substrates,
including  poly (ADP-ribose) polymerase and lamins,
so precipitating the dramatic morphological changes
typical  of  apoptosis.  ICE/caspase-1  (Interleukin-1b-
converting  enzyme)  was  the  first  member  of  the
caspase  family  to  be  identified  as  a  novel  type  of
cysteine protease responsible for the conversion of
precursor Interleukin-1 to its mature form and may be
a key mediator of  inflammation. Our study demon-
strated a significant increase in ICE/caspase-1 level in
serum from allergic asthmatic patients as compared to
control  group,  and  a  correlation  between  baseline
apoptosis of MNC and serum ICE/caspase-1 levels in
atopic asthmatic patients. The increase in the caspase
level  may  be  secondary  to  increased  apoptosis  of
MNC. Alternatively we cannot exclude that it may be
casually related to an increased apoptosis in allergic
patients. In addition to FAS antigen TNF-RI receptor
has been implicated in the apoptosis of lymphocytes
in  several  diseases  including  asthma.31,32 However,
we did not find any significant differences in TNF-a
serum levels between allergic asthmatic patients and
non-allergic subjects, which does not support the role
of TNF-a in observed increased apoptosis of lympho-
cytes in allergic patients. Interestingly, the correlation
between apoptosis of MNC and TNF-a concentration
was present only in control group that may point to
differential  regulation  of  apoptosis  in  allergic  and
healthy subjects.
In conclusion, our study demonstrated an increased
apoptosis  of  MNC  (presumably  lymphocytes)  from
peripheral blood of atopic asthmatic patients and an
increased susceptibility  of  these cells to  mitogen  –
induced apoptosis. In parallel significant changes in
serum  levels  of  sFas  and  ICE/caspase-1, correlating
with apoptosis were observed, suggesting differential
regulation of apoptotic process in peripheral blood
mononuclear  cells  of  patients with  allergic  asthma
and/or rhinitis.
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